Patient leaflets and SmPCs, drug interaction checker, official dosages and NHS pharmacy opening hours — all in one place.
Patient leaflets and SmPCs, drug interaction checker, official dosages and NHS pharmacy opening hours — all in one place.
The electronic medicines compendium (emc) no longer publishes a Summary of Product Characteristics for this product, which usually means it is no longer marketed in the UK. The patient leaflet below is kept for reference, but the product may not be available.
If you were prescribed this medicine, other products containing Mebendazole may still be available. Do not stop your treatment — ask your pharmacist or GP what to use instead.
for
■
Ovex Suspension is a medicine, which is used to treat threadworm (sometimes known as pinworm) infections of the gut. The medicine contains mebendazole, which is one of a group of medicines called 'anthelmintics'. This medicine is for use in adults and children aged over 2 years.
Special warnings about this medicine
If anyone takes too much
Since threadworms can spread very easily, it is strongly recommended that all the family (except pregnant, breast-feeding women or children under 2 years) are treated at the same time and that suitable hygiene precautions are followed to prevent re-infection (see Section 7 of this leaflet for more advice).
If anyone has taken too much Ovex Suspension, contact a doctor or your nearest Accident & Emergency department (Casualty) taking this leaflet and pack with you.
Like all medicines, Ovex can cause side-effects, although not everybody gets them.
This medicine contains sucrose. If you have been told by your doctor that you have an intolerance to some sugars contact your doctor before taking this medicinal product. ■ Methyl (E218) and propyl (E216) parahydroxybenzoate may cause allergic reactions which could possibly be delayed.
If you experience any of the following, stop using the medicine and seek immediate medical help:
Important information on some of the other ingredients in this medicine ■
This medicine is suitable for most adults and children, but a few people should not use it. If you are in any doubt, talk to your doctor or pharmacist.
■
If you have ever had a bad reaction to any of the ingredients. ■ If it is for a child under 2 years. ■ If you are pregnant or think you are pregnant. If any of these apply to you, get advice from a doctor or pharmacist without using Ovex Suspension. ■
This medicine contains less than 1 mmol sodium (23 mg) per 5 mL dose, that is to say essentially 'sodium-free'. This medicine contains 0.819 mg propylene glycol (E1520) in each 5 ml dose, which is equivalent to 0.1638 mg/ml.
e this medicine Do not use this medicine…
CHILD
Project Name / Design Ovex Suspension 30ml/GB/PIL/CRD 13109/1610493A
■
Rare: (may affect up to 1 in 1,000 people) ■ Convulsions (seizures/fits). ■ Allergic reactions including unexplained wheezing, shortness of breath, sudden swelling of your face or throat, and hives (also known as 'nettle rash' or 'urticaria'). ■ Skin rashes (which may be severe and include blistering or peeling of the skin) and itching, and may be accompanied by a high temperature. If you experience any of the following, stop using the medicine and talk to your doctor or pharmacist: Common: (may affect up to 1 in 10 people) Stomach pain Uncommon: (may affect up to 1 in 100 people) ■ Stomach discomfort ■ Diarrhoea ■ Wind ■
100
Other effects that may occur include: Rare: (may affect up to 1 in 1,000 people) ■ Inflammation of the liver or abnormal liver function ■ Reduction in white blood cells (which reduces the body's defences against infection) ■ Unusual hair loss ■ Dizziness Very rare: (may affect up to 1 in 10,000 people) ■ Inflammation of the kidneys* ■ Decrease in bone marrow* activity resulting in reduced production of blood cells ■ Nausea ■ Vomiting *observed in higher and prolonged doses Reporting of side-effects If you experience any side-effects, talk to your doctor, pharmacist or nurse. This includes any possible side-effects not listed in this leaflet. You can also report side-effects directly via the Yellow Card Scheme at www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store. By reporting side-effects, you can help provide more information on the safety of this medicine.
this medicine Check the table below to see how much medicine to take. ■ Always shake the bottle thoroughly before use. ■ The suspension should be taken using the measuring cup provided in the pack. ■ For oral use only.
LARGEST TEXT SIZE
10.00 pt
AVE. TEXT SIZE
Interstate-LightCondensed
FONTS USED
FuturaStd-Book FuturaStd-BookOblique FuturaStd-Heavy FuturaStd-MediumOblique HelveticaWorld-Regular
Leaflet
140 x 295 mm
6.5 pt
SMALLEST TEXT SIZE
4.00 pt
18-12-2020
Lusomedicamenta (Recipharm)
JJEXT_00179_V1
100 WHITE
3p_lus_i_140x295_3LC_v1
Colours represented with a diagonal line have been modified to aid PDF approval.
LITHO OFFSET LITHO OFFSET LITHO OFFSET LITHO OFFSET LITHO OFFSET
Yellow Magenta Cyan Black
REPRESENTATION:
403767658_r0 Product / Eurocode / Mat. ID Code 90546100
PANTONE 286 C
Languages
N/A
Job / Version No.
AW ID N/A
1610493A
Old Component / Item Code
English
PC Spec PC0006331
Date 27-06-2024
100
New Component / Item Code
this medicine Keep this medicine out of the sight and reach of children. Do not use this medicine after the expiry date which is stated on the carton after 'Expiry'. The expiry date refers to the last day of that month. Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help protect the environment.
What's in this medicine? The active ingredient in Ovex Suspension is: Mebendazole 100 mg per 5 ml. Other ingredients are: Sucrose, Microcrystalline cellulose and carmellose sodium, Methylcellulose, Methylparahydroxybenzoate (E218), Propylparahydroxybenzoate (E216), Sodium laurilsulfate, banana flavour, (containing propylene glycol (E1520)), citric acid monohydrate and purified water. (For further information on some of the ingredients see Section 2). What the medicine looks like Ovex Suspension is a banana flavoured, white liquid available in 30 ml packs with a dosing cup. Product Licence holder: McNeil Products Limited, 50 – 100 Holmers Farm Way, High Wycombe, Buckinghamshire, HP12 4EG, UK.
Manufacturer: Lusomedicamenta Sociedade Técnica Farmacêutica,S.A., Estrada Consiglieri Pedroso 66, 69-B, 2730-055 Barcarena, Portugal This leaflet was last revised in June 2024. Ovex is a registered trade mark.
7 Further advice regarding threadworms What are threadworms? Threadworms (Enterobius vermicularis) are tiny white parasitic worms that live in the bowel. They are approximately half an inch long and resemble threads of white cotton
large appetite. Sometimes, threadworms can be transferred to the vagina and urinary passage. This can result in vaginal irritation and discharge, symptoms of cystitis or bed wetting. Who gets threadworms? Anyone, although they are more common in children. It does not mean that your family or your home are not clean. Because threadworms are passed on very easily it is a wise precaution to treat everyone in the family at the same time. How can you tell if someone has threadworms? The most obvious sign of threadworms is intense itching in the anal area, especially at night, although this does not affect everyone. If your children frequently scratch their bottoms, suffer from disturbed sleep or become irritable, it is worth checking their motions and the anal area for tiny white threads. If one member of the family has threadworms, the rest of the family may already have picked up the infection, even if they do not have obvious symptoms. Important note Threadworms only affect humans, they do not affect pets. General advice To ensure that you and your family do not infect others or re-infect yourselves, you should also follow the hygiene measures listed below for at least six weeks: ■ Keep nails short. ■ Discourage nail biting or finger sucking. ■ Wear pyjamas or underclothes in bed. ■ In the mornings, wash thoroughly around the bottom. ■ Provide a towel for the exclusive use of each member of the household. ■ Change clothes regularly. ■ Regularly wash and iron bed linen. ■ Thoroughly wash hands and nails after using the toilet and before each meal. Do you need to keep your children off school? No. As long as the children are treated and the general hygiene measures outlined above are followed, there is no reason to keep them off school. How can you stop the problem coming back? Threadworms are easily treated but unless the following precautions are taken the problem may recur: ■ Follow the general advice above. ■ Make sure everyone in the family is treated at the same time.
GB – 1610493A
Ovex Suspension comes as oral solution. Always follow the dose your doctor or pharmacist has given you, and read the leaflet that comes with the medicine.
The active substance in Ovex Suspension is mebendazole.
This leaflet reproduces the patient information leaflet approved for Ovex Suspension, as published on the electronic medicines compendium (emc). The version printed inside your medicine’s packaging is the one that applies to you.
Whether a medicine is available over the counter or on prescription only depends on its licence. Check the leaflet, or ask your pharmacist — they can tell you straight away.
The text above reproduces the patient information leaflet approved for this medicine, restructured for easier reading.
For the treatment of gastrointestinal infestations of Enterobius vermicularis (threadworm).
There is no evidence that Ovex is effective in the treatment of cysticercosis.
Official guidelines should be taken into consideration.
Posology
Adults and children over 2 years: 1 x 5ml.
Care should be taken to avoid re-infection and it is strongly recommended that all members of the family are treated at the same time.
It is highly recommended that a second dose is taken after two weeks, if re-infection is suspected.
Children under 2 years of age:
This medicine has not been extensively studied in children below the age of 2 years. Currently available data are described in section 4.4, 4.8 and 5.2, but no recommendations on a posology can be made. Because of the lack of sufficient safety data, this medicine should not be used in children below the age of 1 year (see section 4.4, 4.8 and 5.2).
Method of administration
Oral
Precautions to be taken before handling or administering the medicinal product:
The suspension should be shaken before use.
Ovex is contraindicated in pregnancy and in patients who have shown hypersensitivity to the active substance or any of the excipients listed in Section 6.1.
Ovex is not recommended in the treatment of children aged under 2 years.
If symptoms do not disappear within a few days, consult your doctor.
A case-control study of a single outbreak of Stevens-Johnson syndrome/toxic epidermal necrolysis (SJS/TEN) suggested a possible association with the concomitant use of metronidazole with mebendazole. Although there are no additional data on this potential interaction, concomitant use mebendazole and metronidazole should be avoided.
Convulsions in children, including in infants below one year of age, have been reported very rarely during post-marketing experience with Ovex (see section 4.8). Ovex Suspension has not been extensively studied in children below the age of 2 years. Ovex Suspension should only be given to very young children if their worm infestation interferes significantly with their nutritional status and physical development. Therefore, Ovex Suspension should be used in children aged 1-2 years only if the potential benefit justifies the potential risk. Because of the lack of sufficient safety data, Ovex Suspension should not be used in children below the age of 1 year.
Glomerulonephritis and agranulocytosis have been very rarely reported with dosages substantially above those recommended and with treatment for prolonged periods of time.
Patients with rare hereditary problems of fructose intolerance, glucose-galactose malabsorption or sucrose-isomaltase insufficiency should not take this medicine.
Methyl (E218) and propyl (E216) parahydroxybenzoate may cause allergic reactions which could possibly be delayed.
This medicine contains less than 1 mmol sodium (23 mg) per 5 mL dose, that is to say essentially 'sodium-free'.
This medicine contains 0.819 mg propylene glycol (E1520) in each 5ml dose, which is equivalent to 0.1638 mg/ml.
Concomitant treatment with cimetidine may inhibit the metabolism of mebendazole in the liver, resulting in increased plasma concentrations of the drug.
Concomitant use of mebendazole and metronidazole should be avoided (see Section 4.4).
Pregnancy
Since Ovex is contra-indicated in pregnancy, patients who think they are or may be pregnant should not take this preparation.
Lactation
Limited data from case reports demonstrate that a small amount of mebendazole is present in human milk following oral administration. Therefore, caution should be exercised when Ovex is administered to breast-feeding women.
Fertility
The effect on human fertility has not been evaluated.
Ovex does not affect mental alertness or driving ability.
Throughout this section adverse reactions are reported. Adverse reactions are adverse events that were considered to be reasonably associated with the use of mebendazole based on the comprehensive assessment of the available adverse event information. A causal relationship with mebendazole cannot be reliably established in individual cases. Further, because clinical trials are conducted under widely varying conditions, adverse reaction rates observed in the clinical trials of a drug cannot be directly compared to rates in the clinical trials of another drug and may not reflect the rates observed in clinical practice.
At the recommended dose, Ovex is generally well tolerated. However, patients with high parasitic burdens when treated with Ovex have manifested diarrhoea and abdominal pain.
The safety of mebendazole was evaluated in 6276 subjects who participated in 39 clinical trials for the treatment of single or mixed parasitic infestations of the gastrointestinal tract. In these 39 clinical trials, no adverse drug reactions (ADRs) occurred in ≥ 1% of mebendazole-treated subjects.
ADRs identified from clinical trials and post-marketing experience with mebendazole are included in Table 1. The displayed frequency categories use the following convention:
Very common (≥ 1/10); Common (≥ 1/100 and < 1/10); Uncommon (≥ 1/1000 and < 1/100); Rare (≥ 1/10,000 and < 1/1000); Very rare (< 1/10,000); Not known (cannot be estimated from the available data).
Table 1: Adverse Drug Reactions Reported in Clinical Trials and Post‑Marketing Experience for Mebendazole
System Organ Class
Adverse Drug Reactions
Frequency Category
Common
(≥ 1/100 to < 1/10)
Uncommon
(≥ 1/1,000 to < 1/100)
Rare
(≥ 1/10,000 to < 1/1,000)
Very rare
(< 1/10,000)
Blood and lymphatic system disorders
Neutropenia b
Agranulocytosis a, c
Immune system disorders
Hypersensitivity including anaphylactic reaction and anaphylactoid reaction b
Nervous system disorders
Convulsions b
Dizziness a
Gastrointestinal disorders
Abdominal pain a
Abdominal discomfort a;
Diarrhoea a;
Flatulence a;
Nausea b;
Vomiting b
Hepatobiliary disorders
Hepatitis b;
Abnormal liver function tests b
Skin and subcutaneous tissue disorders
Rash a,
Toxic epidermal necrolysis b;
Stevens-Johnson syndrome b;
Exanthema b;
Angioedema b;
Urticaria b;
Alopecia b
Renal and urinary disorders
Glomerulonephritis a, c
a ADR frequency data derived from Clinical Trials or Epidemiological Studies
b Adverse reactions reported during post-marketing surveillance
c Observed in patients treated for Echinococcosis
Reporting of suspected adverse reactions
Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows continued monitoring of the benefit/risk balance of the medicinal product. Healthcare professionals are asked to report any suspected adverse reactions via the Yellow Card Scheme at: www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store.
Agranulocytosis and glomerulonephritis are adverse reactions for Echinococcosis treatment for which the dosage is higher and used for prolonged periods of time compared with other indications; therefore, these are expected symptoms of overdose for non-Echinococcosis indications (see Section 4.8).
Signs and symptoms
In the event of accidental overdosage, abdominal cramps, nausea, vomiting and diarrhoea may occur.
Treatment
There is no specific antidote. Activated charcoal may be given if considered appropriate.
Medicines sold in Romania with the same active substance: Cunoscut în România ca
Same active substance. The strength, the form and whether you need a prescription can differ. Always ask a pharmacist before you switch. Romanian medicines in the UK →
Medicines sold in Poland with the same active substance: W Polsce znany jako
Same active substance. The strength, the form and whether you need a prescription can differ. Always ask a pharmacist before you switch. Polish medicines in the UK →
Ask anything about Ovex Suspension. The assistant answers only from this leaflet — if the leaflet does not cover it, it will say so. It does not give medical advice.
Answers come from the patient leaflet published on the electronic medicines compendium (emc). They are not medical advice. Ask a pharmacist or your GP if you are unsure. For urgent help call NHS 111, or 999 in an emergency.
We use essential cookies to make the site work. We would also like to set optional cookies to understand how the site is used, so we can improve it. We will not set optional cookies unless you accept. See our cookie policy and privacy policy.